‘Holy grail’ blood test for dozens of cancers set to be rejected by NHS after failing early diagnosis trial
NHS hopes for a blood test to detect dozens of cancers from a single sample have been dashed after it failed a £150million trial. The Galleri multi-cancer early detection test is now unlikely to be rolled out on the health service despite catching four times as many cancers as standard screening. It had been billed...
Original Source
Read the full article at Thesun →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.